In September 2026, the ALL ALS Consortium reached an important milestone: more than 2,000 participants had been successfully enrolled across the ASSESS and PREVENT studies.
This achievement represents the collective efforts of ALL ALS’s participants, site teams, and community partners, as well as the general ALS community, who have come together in support of ALS research. Every participant enrollment is a valuable contribution to the program, as each visit completed, assessment conducted, and biosample collected helps researchers build a more comprehensive understanding of ALS and advance treatment development.
As ALL ALS continues to enroll into 2027, we wanted to extend a heartfelt thank you to all of our participants, their caregivers, families, and friends, and every individual who has contributed to our work. We are grateful for your involvement and continued dedication to ALS research.
Together, let’s continue working toward a future without ALS.